Pharmacovigilance and Drug Safety Software Market

Pharmacovigilance and Drug Safety Software Market
Segmentation by Software - Adverse Event Reporting
Software, Drug Safety Audits Software, Issue Tracking
Software, and Fully Integrated Software; End User - Pharma
and Biotech Companies, CROs, BPO Firms, and
Pharmacovigilance Service Providers; Delivery Mode - Onpremise
and Cloud-based and Forecast 2017 - 2022
©2019 Transparency Market Research, All Rights Reserved

Sr. No.
Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Chapter 8
Chapter 9
Chapter 10
Chapter 11
Chapter 12
Chapter 13
Chapter 14
Chapter 15
Content
Preface
Assumptions and Research Methodology
Market Overview
Market Dynamics
Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecasts, By Software Type
Global Pharmacovigilance and Drug Safety Software Market Analysis, by Modality
Global Pharmacovigilance and Drug Safety Software Market Analysis, by Application
Global Pharmacovigilance and Drug Safety Software Market Analysis, by End-user
Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast by Region
North America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Europe Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Latin America Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Middle East & Africa Pharmacovigilance and Drug Safety Software Market Analysis and Forecast
Competition Landscape
©2019 Transparency Market Research, All Rights Reserved

Pharmacovigilance is the profession of monitoring medical drug effects after being
licensed.
The global pharmacovigilance and drug safety software market is envisioned to
attract benefits while riding on the ability of products to avert, evaluate, and
uncover enduring and temporary side effects of certain medications.
Pharmacovigilance software could help to inhibit unnecessary future events and
determine the cause of withdrawal.
Companies are prominently enabled to put into practice proactive safety
surveillance programs with the support provided by pharmacovigilance software as
they push new limits in the market.
©2019 Transparency Market Research, All Rights Reserved

The global pharmacovigilance and drug safety software market to rise at a 5.4%
CAGR between 2017 and 2022.
Rising withdrawals of high-profile drugs has been foretold to augment the
employment of pharmacovigilance tools in the near future.
The usage of these tools could also gain growth because of the swelling pressure on
drug manufacturers to determine early signs of adverse interactions due to drug
consumption.
The demand in the world pharmacovigilance and drug safety software market could
be bolstered with advancement in technology.

The top players of global pharmacovigilance and drug safety software market could
be more into benefit due to the associated use of cutting-edge softwares like Argus
and ARISg.
With easy accessible data and reduced use of outdated data, it has become easier
for players to adopt pharmacovigilance softwares into the market.
Some of the leading players of the market are United BioSource Corporation, AB
Cube, and UMBRA Global LLC.
Players could testify of quick business opportunities owing to the implementation
of such strategies during their operation.
©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website
www.transparencymarketresearch.com
For sales queries or new topics email us on:
sales@transparencymarketresearch.com
Thank You
©2019 Transparency Market Research, All Rights Reserved